Mice neonatally immunosuppressed with anti-,u antiserum failed to produce circulating antibodies to sheep erythrocytes and showed a marked decrease in circulating immunoglobulins. However, when they were intracerebrally infected with Chikungunya virus (a group A togavirus), they showed a mortality rate consistently lower than non-immunosuppressed control mice. Several possible explanations for this finding are discussed.
The role ofthe immune response in the mechanism ofrecovery from viral infections has been studied with different procedures in various virus-host combinations. In many instances, the immunosuppression of the infected animals was used as a tool to explore the different protective roles played in turn by specific and nonspecific defense systems (2, 3, 8, 16, 17, 24) . However, none of the immunosuppressive techniques so far studied specifically suppresses humoral immunity. A system of immunosuppression in vivo that is capable of selective inhibition of humoral immunity without interfering with cell-mediated immunity would be highly desirable.
Recently, this type of immunosuppression has become available after the observation that mice injected from birth with heterologous antiimmunoglobulin ,u chain antisera show absolute suppression of immunoglobulin M (IgM) and IgG antibody production and a marked reduction in all other serum immunoglobulins with no impairment of the cell-mediated immune response (1, 11, 12, 14) . Consequently, the comparison of the course of a viral infection in normal and anti-immunoglobulin-immunosuppressed mice should lead to a less ambiguous evaluation of the role of circulating antibody during a primary infection. We conducted a study to determine the effect of immunosuppression with anti-immunoglobulin antisera on a togavirus encephalitis of mice.
MATERIALS AND METHODS Animals. Brother-sister-mated, inbred BALB/c mice were used; this strain originated from the colony bred in the Animal Production Branch of the National Institutes of Health (Bethesda, Md.).
The anti-,u sera were prepared in the same way as those that were previously shown to specifically inhibit antibody production and not inhibit cell-me- diated immunity (11) .
Antisera. Specifically mouse IgM for immunization of rabbits (male, 3 kg, New Zealand) was obtained as described elsewhere (7) anti-jt antiserum on the day of birth and thereafter every other day with gradually increasing doses; the highest dose, 0.14 ml, was achieved on day 16 and was maintained thereafter throughout the experiment.
The effectiveness of immunosuppression was tested 5 days before viral challenge by injecting every mouse with 108 sheep erythrocytes. Five days later, a sample of blood was harvested from every mouse, and the titer of hemagglutinating and hemolytic antibodies was tested individually. In the control mice the average titer was approximately 1,000, whereas in all the immunosuppressed animals the antibody titers were less than 8. In addition, the electrophoretic pattern of serum obtained from immunosuppressed mice showed a marked decrease of a and y globulin as compared with control mice.
Finally, to show that the immunosuppression did not affect the cell-mediated immune response in the experimental conditions, a duplicate set of mice was immunosuppressed and tested for delayed hypersensitivity to sheep erythrocytes as measured by the footpad swelling method (10) . All immunosuppressed mice reacted with the same degree of delayed hypersensitivity as did control mice. Viral challenge. Chikungunya virus (group A togavirus) was maintained in BHK-21 hamster cell cultures. The virus was then adapted to multiply in the brains of weanling mice by a few serial passages by the intracerebral route. The virus stock used in the experiments was a homogenate of infected brains (1/10 in phosphate-buffered saline) collected 4 days after the infection, when all the mice showed the first symptoms of the disease. The homogenates were centrifuged for 5 min at 3,000 rpm in an International refrigerated centrifuge, and the supernatant, divided into small aliquots, was stored at -70°C until used. The infectious titer was 1056 mean lethal doses. Viral challenge was performed by infecting mice (10 to 12 g body weight) by the intracerebral route with a virus dilution containing 5 mean lethal doses in 0.05 ml. The experiments were continued through day 15. There were no deaths after day 11.
Immunofluorescence. Cerebral damage due either to the inoculation procedures or to viral replication might induce the production of anti-brain antibody. To test this possibility, sera from immunosuppressed and control mice were harvested and tested for the presence of anti-brain antibody by immunofluorescence. This was performed on frozen sections of normal, syngeneic BALB/c mouse brain by using the indirect technique with fluorescentlabeled anti-mouse gamma globulin antisera (Beringwerke).
RESULTS
The results of three representative experiments are shown in Table 1 . The different number of mice reported in each experiment is due to the fact that (i) only the animals that showed effective immunosuppression were infected with Chikungunya virus, and (ii) variable toxicity occurred during the immunosuppressive treatment and only healthy animals were admitted to the experiments. The weight of mice, as determined individually, was the same in the immunosuppressed and in the control groups. In every experiment the mortality was lower in the immunosuppressed group than in the corresponding control group. The variability of the results presented in Table 1 is well within the range expected for virus-induced mortality. Applying the formula of Snedecor and Irwin (18) , the data appear homogeneous and can therefore be cumulated. The cumulative difference is highly significant (P < 0.005).
The time course of the mortality in the two groups of mice is plotted in Fig. 1 . Each point represents the average cumulative mortality (percent) observed at the indicated time after the infection. It can be seen that, except for the deaths that occurred during the first days after the infection (probably due to nonspecific injuries after intracerebral inoculation), the mortality rate was constantly and significantly lower in the immunosuppressed group. No dif- ference in the time of death was observed between the two groups. Neither the immunosuppressed nor the control mice developed antibrain antibody detectable either by immunofluorescence or immunodiffusion.
Blood samples collected on day 10 showed low titers of neutralizing antibody to Chikungunya virus (averaging to 8 U/ml) in the control mice, whereas antibody was not detected (<2 U/ml) in the immunosuppressed animals.
DISCUSSION
The results of this study show that the absence of a humoral immune response not only does not impair the process of recovery from Chikungunya virus encephalitis, but on the contrary, it seems to favor it. The interpretation of these data is not simple. The fact that circulating antibodies may not play a protective role in localized virus infections has been reported in a number of experimental models (2, 3, 8, 16) ; it is, however, difficult to understand how the lack of antibody could decrease the severity of the disease, unless some sort of humoral immune phenomenon plays a role in the pathogenesis of the disease.
A decreased mortality after immunosuppression was previously observed in mice infected with yellow fever (8) , influenza (21, 23) , and lymphocytic choriomeningitis viruses (6); however, none of the immunosuppressive agents used in these studies (X-ray irradiation, antilymphocyte serum, cyclophosphamide) specifically suppressed humoral immunity.
Several hypotheses may be considered to explain the sparing effect of suppression of antibody. (i) The intracerebral infection might cause the production of anti-brain antibodies. This hypothesis has been considered in our study; however, we were unable to detect such antibody in the two groups of mice either by immunodiffusion or immunofluorescent techniques. (ii) The infectious process might be complicated by the development of an immune complex syndrome, as has been shown in the kidneys of mice chronically infected with lymphocytic choriomeningitis virus (6) , but this seems unlikely in the present situation, since acute encephalitis is not characteristic of immune complex diseases. (iii) It has been reported recently that mice immunosuppressed with anti-,u antibody show increased resistance to Friend leukemia virus, and it has been speculated that anti-, treatment could deprive this virus of an appropriate target cell (13) . This hypothesis cannot, however, be applied to our system, as nervous tissue is the target of Chikungunya virus, which also does not replicate in lymphoid mouse cells (unpublished data).
(iv) The production of antiviral antibodies in the presence of complement and lymphoid cells may produce the lysis of cells whose membranes contain viral antigen at an early stage of the disease (19, 20) . The suppression of these antibodies might reduce the cell disruption and, therefore, the anatomical damage. This hypothesis cannot be ruled out. However, ifthis mechanism had played a role in our system, an earlier mortality would have been expected among the control mice as compared with the immunosuppressed mice (8) , and this was not observed. (v) Another hypothesis is that competition for expression of humoral and cellular immune reactivity occurs between T and B cells during the course of the immune response. It has been shown, for instance, that delayed hypersensitivity reactions may be specifically suppressed by B cells (9, 17) . If this phenomenon occurred in our system, it may be speculated that the increased resistance of suppressed mice could be due to a more efficient activation of T cells by antigen, due to the absence of functional B lymphocyte activity. This hypothesis is supported by the finding that T lymphocytes sensitized to Sindbis virus (a togavirus closely related to Chikungunya virus) are able to kill infected cells in vitro before viral maturation and release (15) . It has also been observed that dogs sensitized with measles virus develop a delayed-type response to the related canine distemper virus and acquire a certain level of resistance to this virus, which is almost certainly due to cellular immunity mechanisms, as measles antibodies do not neutralize canine distemper virus in vitro (4) .
The present experimental approach is promising for elucidation of the role of the immune mechanisms in localized, as well as in generalized, virus infections. Thus, expanded studies will be necessary as adequate amounts of antiserum become available. For instance, the determination of viral production in the brain in a parallel set of immunosuppressed mice would be desirable. It will also be important to determine whether the protective effect of antibody suppression correlates with the type of virus maturation or virus spread.
